Ignite Creation Date:
2024-05-06 @ 2:49 PM
Last Modification Date:
2024-10-26 @ 1:37 PM
Study NCT ID:
NCT04433442
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2020-06-04
Brief Title:
Study to Assess the Safety and Change in Disease Symptoms of Risankizumab Skyrizi in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis
Sponsor:
AbbVie
Organization:
AbbVie